See more : Arbe Robotics Ltd. (ARBE) Income Statement Analysis – Financial Results
Complete financial analysis of Tatva Chintan Pharma Chem Limited (TATVA.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tatva Chintan Pharma Chem Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Bank of Ireland Group plc (BIRG.L) Income Statement Analysis – Financial Results
- North American Financial 15 Split Corp. (FNCSF) Income Statement Analysis – Financial Results
- Castellum AB (publ) (CWQXF) Income Statement Analysis – Financial Results
- Subaru Corporation (7270.T) Income Statement Analysis – Financial Results
- AMCI Acquisition Corp. II (AMCIU) Income Statement Analysis – Financial Results
Tatva Chintan Pharma Chem Limited (TATVA.BO)
About Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited engages in manufacture and sale of specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor and zinc ion batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also engages in trading of specialty chemicals. The company serves various industries, including the automotive, petroleum, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. It also exports its products to various countries, including the United States, Singapore, the United Kingdom, China, Germany, Japan, and South Africa. The company was incorporated in 1996 and is headquartered in Vadodara, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 3.90B | 4.21B | 4.31B | 2.97B | 2.58B | 2.02B | 1.34B |
| Cost of Revenue | 3.20B | 2.35B | 2.08B | 1.58B | 1.38B | 1.16B | 1.02B |
| Gross Profit | 700.68M | 1.86B | 2.24B | 1.38B | 1.19B | 861.48M | 321.59M |
| Gross Profit Ratio | 17.94% | 44.26% | 51.85% | 46.66% | 46.28% | 42.55% | 24.05% |
| Research & Development | 79.42M | 60.39M | 37.03M | 2.79M | 10.14M | 1.99M | 1.89M |
| General & Administrative | 58.90M | 50.67M | 43.84M | 26.69M | 22.74M | 39.53M | 0.00 |
| Selling & Marketing | 225.13M | 287.66M | 330.57M | 187.79M | 160.97M | 149.37M | 0.00 |
| SG&A | 219.26M | 338.33M | 374.41M | 214.48M | 183.71M | 188.90M | 132.62M |
| Other Expenses | 0.00 | 3.68M | 1.33M | 10.53M | -2.10M | 390.00K | -2.04M |
| Operating Expenses | 642.47M | 1.28B | 1.23B | 784.64M | 656.24M | 541.05M | 136.55M |
| Cost & Expenses | 3.51B | 3.62B | 3.30B | 2.37B | 2.04B | 1.70B | 1.15B |
| Interest Income | 23.96M | 53.34M | 46.68M | 3.59M | 5.17M | 2.71M | 3.11M |
| Interest Expense | 61.51M | 79.97M | 43.51M | 39.85M | 37.52M | 32.98M | 26.10M |
| Depreciation & Amortization | 256.05M | 95.55M | 81.80M | 67.32M | 47.93M | 40.18M | 29.52M |
| EBITDA | 756.71M | 626.96M | 1.17B | 717.71M | 566.19M | 353.39M | 226.97M |
| EBITDA Ratio | 19.38% | 15.70% | 27.07% | 24.08% | 21.82% | 16.77% | 16.05% |
| Operating Income | 422.17M | 579.35M | 1.01B | 605.84M | 488.63M | 281.32M | 185.04M |
| Operating Income Ratio | 10.81% | 13.76% | 23.32% | 20.41% | 18.96% | 13.90% | 13.84% |
| Total Other Income/Expenses | 13.51M | -131.56M | 35.23M | 1.12M | -60.24M | -46.50M | 5.30M |
| Income Before Tax | 435.68M | 447.79M | 1.04B | 606.96M | 475.97M | 273.93M | 190.34M |
| Income Before Tax Ratio | 11.16% | 10.64% | 24.14% | 20.45% | 18.47% | 13.53% | 14.24% |
| Income Tax Expense | 132.14M | -7.08M | 82.47M | 84.34M | 98.08M | 68.50M | 67.45M |
| Net Income | 303.54M | 454.87M | 958.74M | 522.62M | 377.89M | 205.43M | 122.89M |
| Net Income Ratio | 7.77% | 10.81% | 22.23% | 17.61% | 14.66% | 10.15% | 9.19% |
| EPS | 13.26 | 20.52 | 44.59 | 26.02 | 18.81 | 10.23 | 6.12 |
| EPS Diluted | 13.26 | 20.52 | 44.59 | 26.02 | 18.81 | 10.23 | 6.12 |
| Weighted Avg Shares Out | 22.89M | 22.17M | 21.50M | 20.09M | 20.09M | 20.09M | 20.09M |
| Weighted Avg Shares Out (Dil) | 22.89M | 22.17M | 21.50M | 20.09M | 20.09M | 20.09M | 20.09M |
Source: https://incomestatements.info
Category: Stock Reports